CD8A and neoplasm: As PD‐1 is a marker of effector T‐cells [31], it appears that the anti‐tumor immune response may be blunted in the outer stroma adjacent to tumor tissues due to the interaction with PD‐L1 and PD‐1 in CD8+ immune cells.